These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2822850)

  • 1. Pharmacological properties of EXP 561, a potential antidepressant drug.
    Maj J; Skuza G; Sowińska H; Nowak G
    J Neural Transm; 1987; 70(1-2):81-97. PubMed ID: 2822850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The central action of carbamazepine as a potential antidepressant drug.
    Maj J; Chojnacka-Wójcik E; Lewandowska A; Tatarczyńska E; Wiczyńska B
    Pol J Pharmacol Pharm; 1985; 37(1):47-56. PubMed ID: 4041037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central effects following repeated treatment with antidepressant drugs.
    Maj J
    Pol J Pharmacol Pharm; 1984; 36(2-3):87-99. PubMed ID: 6089162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some central effects of tiflucarbine, a new potential antidepressant drug.
    Maj J; Rogóz Z; Sowińska H; Zalewski Z
    Pol J Pharmacol Pharm; 1987; 39(1):63-74. PubMed ID: 2823240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant activities of WEB 1881, a new nootropic agent.
    Maj J; Rogóz Z; Skuza G; Sowińska H; Nowak G
    Pol J Pharmacol Pharm; 1989; 41(5):439-52. PubMed ID: 2561889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacological profile of dexamisole.
    Przegaliński E; Bigajska K; Siwanowicz J
    Pol J Pharmacol Pharm; 1980; 32(1):21-9. PubMed ID: 7454609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant profile of 9-methyl-2[-3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-beta- carbolin-1-one (B-193).
    Wiczyńska B; Antkiewicz-Michaluk L; Pilc A; Chojnacka-Wójcik E; Przegaliński E
    Pol J Pharmacol Pharm; 1989; 41(4):331-44. PubMed ID: 2636891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the alpha 1-adrenergic, dopamine and serotonin systems.
    Maj J; Rogóz Z
    J Neural Transm (Vienna); 1999; 106(2):197-211. PubMed ID: 10226939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profile of reboxetine, a representative of new class of antidepressant drugs, selective noradrenaline reuptake inhibitor (NARI), given acutely.
    Rogóz Z; Wróbel A; Krasicka-Domka M; Maj J
    Pol J Pharmacol; 1999; 51(5):399-404. PubMed ID: 10817540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril lacks the antidepressant-like activity in animal models.
    Baran L; Siwanowicz J; Nowak G; Przegaliński E
    Pol J Pharmacol Pharm; 1991; 43(4):265-70. PubMed ID: 1667333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of milnacipran, a new antidepressant, given acutely.
    Rogóz Z; Skuza G; Maj J
    Pol J Pharmacol; 1999; 51(4):317-22. PubMed ID: 10540963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological profile of Org 6906, a potential non-sedative antidepressant that combines monoamine uptake inhibition with alpha 2-adrenolytic activity.
    de Boer T; Broekkamp CL; Gower A; de Graaf JS; de Vos CJ; Rae D; Van Delft AM
    Neuropharmacology; 1988 Mar; 27(3):251-60. PubMed ID: 2897643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of venlafaxine, a new antidepressant, given acutely.
    Rogóz Z; Dziedzicka-Wasylewska M; Maj J
    Pol J Pharmacol; 1998; 50(2):107-15. PubMed ID: 9798262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated trimipramine induces dopamine D2/D3 and alpha1-adrenergic up-regulation.
    Maj J; Rogóz Z; Skuza G; Margas W
    J Neural Transm (Vienna); 1998; 105(2-3):329-42. PubMed ID: 9660111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some central pharmacological effects of (+)- and (-)-oxaprotiline.
    Maj J; Rogóź Z; Skuza G; Sowińska H
    J Neural Transm Gen Sect; 1990; 80(2):129-43. PubMed ID: 2317315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central action of the antidepressant drug pirlindole.
    Maj J; Michaluk J; Rawłów A; Rogóz Z; Skuza G
    Arzneimittelforschung; 1986 Aug; 36(8):1198-201. PubMed ID: 3490854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological effects of milnacipran, a new antidepressant, given repeatedly on the alpha1-adrenergic and serotonergic 5-HT2A systems.
    Maj J; Rogóz Z; Dlaboga D; Dziedzicka-Wasylewska M
    J Neural Transm (Vienna); 2000; 107(11):1345-59. PubMed ID: 11145008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice.
    Eshel G; Ross SB; Kelder D; Edis LE; Jackson DM
    Pharmacol Toxicol; 1990 Aug; 67(2):123-31. PubMed ID: 1979437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flerobuterol: a potential antidepressant drug related to beta-adrenergic agonists. Experimental profile in mice.
    Duteil J; Rambert FA; Pointeau AM; Mangiameli P; Assous E
    Fundam Clin Pharmacol; 1991; 5(8):695-708. PubMed ID: 1686009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1996; 48(4):379-95. PubMed ID: 9112678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.